Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Measurements of Tumor Cell Autophagy Predict Invasiveness, Resistance to Chemotherapy, and Survival in Melanoma

Open access

Published version of a preprint

Abstract

Purpose: Autophagy consists of lysosome-dependent degradation of cytoplasmic contents sequestered by autophagic vesicles (AV). The role of autophagy in determining tumor aggressiveness and response to therapy in melanoma was investigated in this study. Experimental Design: Autophagy was measured in tumor biopsies obtained from metastatic melanoma patients enrolled on a phase II trial of temozolomide and sorafenib and correlated to clinical outcome. These results were compared with autophagy measurements in aggressive and indolent melanoma cells grown in two- and three-dimensional (3D) culture and as xenograft tumors. The effects of autophagy inhibition with either hydroxychloroquine or inducible shRNA (short hairpin RNA) against the autophagy gene ATG5 were assessed in three-dimensional spheroids. Results: Patients whose tumors had a high autophagic index were less likely to respond to treatment and had a shorter survival compared with those with a low autophagic index. Differences in autophagy were less evident in aggressive and indolent melanoma cells grown in monolayer culture. In contrast, autophagy was increased in aggressive compared with indolent melanoma xenograft tumors. This difference was recapitulated when aggressive and indolent melanoma cells were grown as spheroids. Autophagy inhibition with either hydroxychloroquine or inducible shRNA against ATG5 resulted in cell death in aggressive melanoma spheroids, and significantly augmented temozolomide-induced cell death. Conclusions: Autophagy is a potential prognostic factor and therapeutic target in melanoma. Three dimensional culture mimics the tumor microenvironment better than monolayer culture and is an appropriate model for studying therapeutic combinations involving autophagy modulators. Autophagy inhibition should be tested clinically in patients with melanoma. Clin Cancer Res; 17(10); 3478–89. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-10-2372

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 40 · Cited by 234

Metadata

Authors
Ma, X.-H., Piao, S., Wang, D., Mcafee, Q. W., Nathanson, K. L., Lum, J. J., Li, L. Z., & Amaravadi, R. K.
Affiliations
  • Authors' Affiliations: 1Division of Hematology-Oncology, Department of Medicine; 2Abramson Cancer Center; 3Department of Radiology; 4Division of Medical Genetics, Department of Medicine; 5Institute of Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania; and 6Trev and Joyce Deeley Research Centre, BC Cancer Agency, Victoria, British Columbia, Canada
  • BC Cancer Agency (CA)
Corresponding author
Amaravadi, Ravi K.
Venue
Clinical Cancer Research
Published
2011-05-15
Volume
17
Issue
10
Pages
3478-3489
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2139830524
Cited by
234
References
40
Citations by year
2026: 1 · 2025: 5 · 2024: 16 · 2023: 6 · 2022: 17 · 2021: 13 · 2020: 16 · 2019: 13 · 2018: 13 · 2017: 19 · 2016: 25 · 2015: 23 · 2014: 20 · 2013: 20 · 2012: 18
FWCI
15.99
Type
journal article
Language
en
Open access
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Abramson Cancer Center
  • National Cancer Institute (U54CA105008, K23CA120862, U24CA083105)
  • National Center for Research Resources (RR02305, P41RR002305)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
Keywords
autophagy, melanoma, metastatic melanoma, tumor invasion, chemoresistance, temozolomide, sorafenib, hydroxychloroquine, ATG5, autophagy inhibition, multicellular spheroids, tumor xenografts, prognostic factors, therapeutic target, tumor microenvironment
MeSH terms
Sorafenib, Temozolomide, Animals, Antineoplastic Combined Chemotherapy Protocols, Autophagy, Benzenesulfonates, Cell Count, Dacarbazine, Humans, Melanoma, Mice, Nude, Neoplasm Invasiveness, Niacinamide, Phenylurea Compounds, Prognosis, Pyridines, Skin Neoplasms, Tumor Cells, Cultured, Survival Analysis, Clinical Trials, Phase II as Topic, Drug Resistance, Neoplasm, Xenograft Model Antitumor Assays, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Measurements of Tumor Cell Autophagy Predict Invasiveness, Resistance to Chemotherapy, and Survival in Melanoma. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-10-2372
The paper
Ma, X.-H., Piao, S., Wang, D., Mcafee, Q. W., Nathanson, K. L., Lum, J. J., Li, L. Z., & Amaravadi, R. K. (2011). Measurements of Tumor Cell Autophagy Predict Invasiveness, Resistance to Chemotherapy, and Survival in Melanoma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-10-2372

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.